Actinium Pharmaceuticals
ATNM
ATNM
30 hedge funds and large institutions have $8.43M invested in Actinium Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.21% more ownership
Funds ownership: 0.23% → 0.44% (+0.21%)
Holders
30
Holding in Top 10
–
Calls
$27K
Puts
–
Top Buyers
| 1 | +$2.16M | |
| 2 | +$1.87M | |
| 3 | +$145K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$122K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$49.8K |
Top Sellers
| 1 | -$247K | |
| 2 | -$61.4K | |
| 3 | -$43K | |
| 4 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$19.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9K |